|
1
|
de Martel C, Forman D and Plummer M:
Gastric cancer: epidemiology and risk factors. Gastroenterol Clin
North Am. 42:219–240. 2013.
|
|
2
|
Fock KM: Review article: the epidemiology
and prevention of gastric cancer. Aliment Pharmacol There.
40:250–260. 2014.
|
|
3
|
Bollschweiler E, Berlth F, Baltin C, et
al: Treatment of early gastric cancer in the Western World. World J
Gastroenterol. 20:5672–5678. 2014.
|
|
4
|
Sheikh A, Alvi AA, Aslam HM and Haseeb A:
Hedgehog pathway inhibitors - current status and future propects.
Infect Agent Cancer. 7:292012.
|
|
5
|
Gerardo Valadez J, Grover VK, Carter MD,
et al: Identification of Hedgehog pathway responsive glioblastomas
by isocitrate dehydrogenase mutation. Cancer Lett. 328:297–306.
2013.
|
|
6
|
Yun JI, Kim HR, Park H, et al: Small
molecule inhibitors of the hedgehog signaling pathway for the
treatment of cancer. Arch Pharm Res. 35:1317–1333. 2012.
|
|
7
|
Queiroz KC, Spek CA and Peppelenbosch MP:
Targeting Hedgehog signaling and understanding refractory response
to treatment with Hedgehog pathway inhibitors. Drug Resist Updat.
15:211–222. 2012.
|
|
8
|
Cobourne MT and Green JB: Hedgehog
signaling in development of the secondary palate. Front Oral Biol.
16:52–59. 2012.
|
|
9
|
Büller NV, Rosekrans SL, Westerlund J, et
al: Hedgehog signaling and maintenance of homeostasis in intestinal
epithelium. Physiology (Bethesda). 27:148–155. 2012.
|
|
10
|
Viatte S, Plant D and Raychaudhuri S:
Genetics and epigenetics of rheumatoid arthritis. Nat Rev
Rheumatol. 9:141–153. 2013.
|
|
11
|
Eising E, A Datson N, van den Maagdenberg
AM and Ferrari MD: Epigenetic mechanisms in migraine: a promising
avenue. BMC Med. 11:262013.
|
|
12
|
Hodes GE: Sex, stress, and epigenetics:
regulation of behavior in animal models of mood disorders. Biol Sex
Differ. 4:12013.
|
|
13
|
Toraño EG, Petrus S, Fernandez AF and
Fraga MF: Global DNA hypomethylation in cancer: review of validated
and clinical significance. Clin Chem Lab Med. 50:1733–1742.
2012.
|
|
14
|
Savio AJ, Lemire M, Mrkonjic M, et al:
MLH1 region polymorphisms show a significant association with CpG
island shore methylation in a large cohort of healthy individuals.
PLoS One. 7:e515312012.
|
|
15
|
Kim JG, Takeshima H, Niwa T, et al:
Comprehensive DNA methylation and extensive mutation analyses
reveal an association between the CpG island methylator phenotype
and oncogenic mutations in gastric cancers. Cancer Lett. 330:33–40.
2013.
|
|
16
|
Anastasiadou C, Malousi A, Maglaveras N
and Kouidou S: Human epigenome data reveal increased CpG
methylation in alternatively spliced sites and putative exonic
splicing enhancers. DNA Cell Biol. 30:267–275. 2011.
|
|
17
|
Lu JT, Zhao WD, He W and Wei W: Hedgehog
signaling pathway mediates invasion and metastasis of
hepatocellular carcinoma via ERK pathway. Acta Pharmacol Sin.
33:691–700. 2012.
|
|
18
|
Yun JI, Kim HR, Park H, et al: Small
molecule inhibitors of the hedgehog signaling pathway for the
treatment of cancer. Arch Pharm Res. 35:1317–1333. 2012.
|
|
19
|
Pan JY and Zhou SH: The hedgehog
signaling, a new therapeutic target for treatment of ischemic heart
disease. Pharmazie. 67:475–481. 2012.
|
|
20
|
Lee JH, Park SJ, Abraham SC, et al:
Frequent CpG island methylation in precursor lesions and early
gastric adenocarcinomas. Oncogene. 23:4646–4654. 2004.
|
|
21
|
Berman A, Mezey M, Kobayashi M, et al:
Gerontological nursing content in baccalaureate nursing programs:
comparison of findings from 1997 and 2003. J Prof Nurs. 21:268–275.
2005.
|
|
22
|
Shahi MH, Lorente A and Castresana JS:
Hedgehog signalling in medulloblas toma, glioblastoma and
neuroblastoma. Oncol Rep. 19:681–688. 2008.
|
